Qingdao Port in Shandong province [Photo/VCG]

Since the start of this year, foreign trade enterprises in Shandong have been actively responding to changes in the domestic and foreign economic situation and increased scientific and technological innovation, while governments at all levels have strengthened services, solved problems for enterprises, and boosted foreign trade.

Recently, 7.5 million rosuvastatin calcium tablets from Lunan Pharmaceutical Group were shipped to the United States, marking the first time the company has exported the product to the US.

"Rosuvastatin calcium tablets are currently routinely used in the treatment of hyperlipidemia and are in great demand. We expect to produce more than 100 million tablets next year, and in two years, we expect to export 200 million tablets, which would account for 20 percent of the global market," said Xun Mingjin, a shop manager of Lunan Pharmaceutical.

Export growth is inseparable from scientific and technological innovation among enterprises. This year, Shandong highlighted scientific and technological innovation and encouraged enterprises to increase technological breakthroughs.

Lunan Pharmaceutical has set up an international drug research and development center and will invest 150 million yuan ($21.74 million) in global drug R&D every year.

Lunan Pharmaceutical has completed R&D and registration for 44 preparations in 80 countries, and its products are exported to more than 60 countries and regions, with the annual export value exceeding 1 billion yuan.

Since the beginning of this year, Shandong has introduced more than 30 policies and measures to stabilize foreign trade, and it has met more than 2,800 enterprises' demands in terms of employment, customs clearance, logistics and other issues.